191 related articles for article (PubMed ID: 27567812)
1. Shear-Induced Amyloid Formation in the Brain: I. Potential Vascular and Parenchymal Processes.
Trumbore CN
J Alzheimers Dis; 2016 Sep; 54(2):457-70. PubMed ID: 27567812
[TBL] [Abstract][Full Text] [Related]
2. Shear-Induced Amyloid Aggregation in the Brain: V. Are Alzheimer's and Other Amyloid Diseases Initiated in the Lower Brain and Brainstem by Cerebrospinal Fluid Flow Stresses?
Trumbore CN
J Alzheimers Dis; 2021; 79(3):979-1002. PubMed ID: 33386802
[TBL] [Abstract][Full Text] [Related]
3. Shear-Induced Amyloid Formation in the Brain: III. The Roles of Shear Energy and Seeding in a Proposed Shear Model.
Trumbore CN
J Alzheimers Dis; 2018; 65(1):47-70. PubMed ID: 30040710
[TBL] [Abstract][Full Text] [Related]
4. Suppression of glymphatic fluid transport in a mouse model of Alzheimer's disease.
Peng W; Achariyar TM; Li B; Liao Y; Mestre H; Hitomi E; Regan S; Kasper T; Peng S; Ding F; Benveniste H; Nedergaard M; Deane R
Neurobiol Dis; 2016 Sep; 93():215-25. PubMed ID: 27234656
[TBL] [Abstract][Full Text] [Related]
5. Perivascular drainage of amyloid-beta peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer's disease.
Weller RO; Subash M; Preston SD; Mazanti I; Carare RO
Brain Pathol; 2008 Apr; 18(2):253-66. PubMed ID: 18363936
[TBL] [Abstract][Full Text] [Related]
6. Clusterin levels are increased in Alzheimer's disease and influence the regional distribution of Aβ.
Miners JS; Clarke P; Love S
Brain Pathol; 2017 May; 27(3):305-313. PubMed ID: 27248362
[TBL] [Abstract][Full Text] [Related]
7. In vivo assessment of brain interstitial fluid with microdialysis reveals plaque-associated changes in amyloid-beta metabolism and half-life.
Cirrito JR; May PC; O'Dell MA; Taylor JW; Parsadanian M; Cramer JW; Audia JE; Nissen JS; Bales KR; Paul SM; DeMattos RB; Holtzman DM
J Neurosci; 2003 Oct; 23(26):8844-53. PubMed ID: 14523085
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological removal of serum amyloid P component from intracerebral plaques and cerebrovascular Aβ amyloid deposits in vivo.
Al-Shawi R; Tennent GA; Millar DJ; Richard-Londt A; Brandner S; Werring DJ; Simons JP; Pepys MB
Open Biol; 2016 Feb; 6(2):150202. PubMed ID: 26842068
[TBL] [Abstract][Full Text] [Related]
9. Cerebral amyloid angiopathy: amyloid beta accumulates in putative interstitial fluid drainage pathways in Alzheimer's disease.
Weller RO; Massey A; Newman TA; Hutchings M; Kuo YM; Roher AE
Am J Pathol; 1998 Sep; 153(3):725-33. PubMed ID: 9736023
[TBL] [Abstract][Full Text] [Related]
10. Cerebral amyloid angiopathy and Alzheimer disease - one peptide, two pathways.
Greenberg SM; Bacskai BJ; Hernandez-Guillamon M; Pruzin J; Sperling R; van Veluw SJ
Nat Rev Neurol; 2020 Jan; 16(1):30-42. PubMed ID: 31827267
[TBL] [Abstract][Full Text] [Related]
11. Origins of Beta Amyloid Differ Between Vascular Amyloid Deposition and Parenchymal Amyloid Plaques in the Spinal Cord of a Mouse Model of Alzheimer's Disease.
Yuan Q; Liu X; Xian YF; Tang Y; Zou J; Zhang X; Huang P; Wu W; Song YQ; Lin ZX
Mol Neurobiol; 2020 Jan; 57(1):278-289. PubMed ID: 31325023
[TBL] [Abstract][Full Text] [Related]
12. Murine versus human apolipoprotein E4: differential facilitation of and co-localization in cerebral amyloid angiopathy and amyloid plaques in APP transgenic mouse models.
Liao F; Zhang TJ; Jiang H; Lefton KB; Robinson GO; Vassar R; Sullivan PM; Holtzman DM
Acta Neuropathol Commun; 2015 Nov; 3():70. PubMed ID: 26556230
[TBL] [Abstract][Full Text] [Related]
13. Capillary and arterial cerebral amyloid angiopathy in Alzheimer's disease: defining the perivascular route for the elimination of amyloid beta from the human brain.
Preston SD; Steart PV; Wilkinson A; Nicoll JA; Weller RO
Neuropathol Appl Neurobiol; 2003 Apr; 29(2):106-17. PubMed ID: 12662319
[TBL] [Abstract][Full Text] [Related]
14. Tg-SwDI transgenic mice exhibit novel alterations in AbetaPP processing, Abeta degradation, and resilient amyloid angiopathy.
Van Vickle GD; Esh CL; Daugs ID; Kokjohn TA; Kalback WM; Patton RL; Luehrs DC; Walker DG; Lue LF; Beach TG; Davis J; Van Nostrand WE; Castaño EM; Roher AE
Am J Pathol; 2008 Aug; 173(2):483-93. PubMed ID: 18599612
[TBL] [Abstract][Full Text] [Related]
15. Human apolipoprotein E4 alters the amyloid-beta 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model.
Fryer JD; Simmons K; Parsadanian M; Bales KR; Paul SM; Sullivan PM; Holtzman DM
J Neurosci; 2005 Mar; 25(11):2803-10. PubMed ID: 15772340
[TBL] [Abstract][Full Text] [Related]
16. Resting microglia react to Aβ42 fibrils but do not detect oligomers or oligomer-induced neuronal damage.
Ferrera D; Mazzaro N; Canale C; Gasparini L
Neurobiol Aging; 2014 Nov; 35(11):2444-2457. PubMed ID: 24973120
[TBL] [Abstract][Full Text] [Related]
17. Early-onset formation of parenchymal plaque amyloid abrogates cerebral microvascular amyloid accumulation in transgenic mice.
Xu F; Kotarba AE; Ou-Yang MH; Fu Z; Davis J; Smith SO; Van Nostrand WE
J Biol Chem; 2014 Jun; 289(25):17895-908. PubMed ID: 24828504
[TBL] [Abstract][Full Text] [Related]
18. Shear-Induced Amyloid Formation in the Brain: IV. Effects on Synapses Surrounding Senile Plaque and in Plaque-Free Regions.
Trumbore CN
J Alzheimers Dis; 2018; 66(1):57-73. PubMed ID: 30223395
[TBL] [Abstract][Full Text] [Related]
19. Vascular and parenchymal amyloid pathology in an Alzheimer disease knock-in mouse model: interplay with cerebral blood flow.
Li H; Guo Q; Inoue T; Polito VA; Tabuchi K; Hammer RE; Pautler RG; Taffet GE; Zheng H
Mol Neurodegener; 2014 Aug; 9():28. PubMed ID: 25108425
[TBL] [Abstract][Full Text] [Related]
20. Aβ43 in human Alzheimer's disease: effects of active Aβ42 immunization.
Jäkel L; Boche D; Nicoll JAR; Verbeek MM
Acta Neuropathol Commun; 2019 Sep; 7(1):141. PubMed ID: 31477180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
